Chiron Investment Management LLC purchased a new stake in Atlassian Co. (NASDAQ:TEAM - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 3,371 shares of the technology company's stock, valued at approximately $820,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of TEAM. Belpointe Asset Management LLC purchased a new stake in shares of Atlassian during the 4th quarter valued at $934,000. CreativeOne Wealth LLC purchased a new stake in Atlassian in the fourth quarter valued at about $221,000. Mariner LLC boosted its holdings in Atlassian by 19.4% in the fourth quarter. Mariner LLC now owns 10,036 shares of the technology company's stock worth $2,443,000 after acquiring an additional 1,634 shares in the last quarter. Summit Investment Advisors Inc. grew its stake in shares of Atlassian by 6.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 5,137 shares of the technology company's stock worth $1,250,000 after acquiring an additional 322 shares during the last quarter. Finally, Townsquare Capital LLC grew its stake in shares of Atlassian by 53.4% during the fourth quarter. Townsquare Capital LLC now owns 2,052 shares of the technology company's stock worth $499,000 after acquiring an additional 714 shares during the last quarter. Hedge funds and other institutional investors own 94.45% of the company's stock.
Atlassian Price Performance
Shares of TEAM traded down $2.56 during trading hours on Friday, hitting $202.75. 1,564,440 shares of the stock were exchanged, compared to its average volume of 2,044,340. The stock's 50-day moving average price is $241.92 and its two-hundred day moving average price is $241.88. Atlassian Co. has a 12-month low of $135.29 and a 12-month high of $326.00. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.24 and a current ratio of 1.24. The company has a market cap of $53.12 billion, a price-to-earnings ratio of -151.30 and a beta of 1.07.
Atlassian (NASDAQ:TEAM - Get Free Report) last issued its earnings results on Thursday, January 30th. The technology company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of $0.73 by ($0.85). Atlassian had a negative return on equity of 17.37% and a negative net margin of 7.22%. Research analysts expect that Atlassian Co. will post -0.34 earnings per share for the current year.
Insider Activity
In other Atlassian news, CAO Gene Liu sold 568 shares of the business's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $312.08, for a total value of $177,261.44. Following the sale, the chief accounting officer now owns 52,142 shares of the company's stock, valued at $16,272,475.36. The trade was a 1.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Scott Farquhar sold 7,948 shares of the firm's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $255.71, for a total value of $2,032,383.08. Following the transaction, the director now owns 381,504 shares of the company's stock, valued at $97,554,387.84. This trade represents a 2.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 261,513 shares of company stock valued at $67,123,959 in the last 90 days. Company insiders own 38.55% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts recently commented on the stock. Wells Fargo & Company lowered their target price on shares of Atlassian from $375.00 to $330.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. BMO Capital Markets dropped their price objective on shares of Atlassian from $360.00 to $295.00 and set an "outperform" rating on the stock in a report on Thursday, April 10th. StockNews.com lowered Atlassian from a "buy" rating to a "hold" rating in a research note on Monday, March 31st. Macquarie raised Atlassian from a "neutral" rating to an "outperform" rating and cut their price objective for the company from $317.00 to $270.00 in a report on Thursday, April 10th. Finally, Canaccord Genuity Group lifted their target price on Atlassian from $255.00 to $285.00 and gave the stock a "buy" rating in a report on Friday, December 20th. Six investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $297.73.
Read Our Latest Analysis on TEAM
About Atlassian
(
Free Report)
Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.
See Also

Before you consider Atlassian, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atlassian wasn't on the list.
While Atlassian currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.